WRBYWarby Parker Inc.
Price
-11%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, demanding price, growth steady, the market undecided.
Warby Parker is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. We stand for fun, creativity, and doing good in the world. Every day, our team of over 4,000 employees is focused on our mission to inspire and impact the world with vision, purpose, and style (without charging a premium for it). Our ultimate objective is to provide vision for all.
In the company’s own words · 10-K filed Feb 26, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Warby Parker Inc. (WRBY) reported revenue of $236M in Q2 2026 (quarter ended Jun 30, 2026), up 9.8% from the same quarter a year earlier. That came with a gross margin of 58% and net income of $4.6M (2.0% of revenue). For the full year FY2025, revenue was $872M (+13% year on year) and net income $1.6M. Its largest product in Q2 2026 was Eyewear Products at $192M, 81% of the disclosed total, well ahead of Contacts at 11%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Feb 26, 2026On February 26, 2026, the Company announced that its Board of Directors authorized a share repurchase program to purchase up to $100.0 million of the Company’s Class A common stock (the “Share Repurchase Program”)Earnings release · Form 8-K
- Feb 9, 2026On February 4, 2026, the Board of Directors (the “Board”) of Warby Parker Inc. (the “Company”) appointed Adrian Mitchell as Chief Financial Officer of the Company, effective as of February 10, 2026 (the “Effective Date”)Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $235.5MThe company’s own SEC segment disclosure.
- Eyewear Products$191.8M81%
- Contacts$26.6M11%
- Eye Care$17.2M7%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
Ranks #19 of 21 by RyuScore